A Phase I Double-blind, Randomized, Comparator-controlled Study of the Safety and Tolerability of N-acetylcysteine Plus Mesalamine Enema in Subjects With Left-sided Ulcerative Colitis.

Trial Profile

A Phase I Double-blind, Randomized, Comparator-controlled Study of the Safety and Tolerability of N-acetylcysteine Plus Mesalamine Enema in Subjects With Left-sided Ulcerative Colitis.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Mar 2011

At a glance

  • Drugs Mesalazine/acetylcysteine (Primary) ; Mesalazine
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Jan 2011 Results reported in an Altheus Therapeutics media release.
    • 06 Jan 2011 Status changed from recruiting to completed according to an Altheus Therapeutics media release.
    • 19 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top